Jane Street’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.43M Buy
14,998
+5,984
+66% +$3.84M ﹤0.01% 2755
2025
Q4
$6.1M Sell
9,014
-23,781
-73% -$16.2M ﹤0.01% 2944
2025
Q3
$21M Buy
32,795
+19,566
+148% +$11.9M ﹤0.01% 1626
2025
Q2
$7.1M Buy
13,229
+5,668
+75% +$2.71M ﹤0.01% 2559
2025
Q1
$3.18M Sell
7,561
-18,980
-72% -$8.24M ﹤0.01% 3629
2024
Q4
$11M Buy
26,541
+24,214
+1,041% +$10.6M ﹤0.01% 1797
2024
Q3
$1.18M Sell
2,327
-40,715
-95% -$19.8M ﹤0.01% 5562
2024
Q2
$21M Buy
43,042
+19,785
+85% +$9.93M ﹤0.01% 1278
2024
Q1
$12.6M Sell
23,257
-2,908
-11% -$1.59M ﹤0.01% 1593
2023
Q4
$14.5M Buy
26,165
+13,719
+110% +$6.44M ﹤0.01% 1559
2023
Q3
$5.44M Sell
12,446
-17,629
-59% -$8.79M ﹤0.01% 2499
2023
Q2
$15.1M Buy
30,075
+14,515
+93% +$6.96M 0.01% 1487
2023
Q1
$7.78M Sell
15,560
-14,957
-49% -$7.16M ﹤0.01% 1896
2022
Q4
$12.4M Buy
30,517
+10,481
+52% +$4.07M 0.01% 1403
2022
Q3
$6.53M Sell
20,036
-44,076
-69% -$16.2M ﹤0.01% 2212
2022
Q2
$22.5M Buy
64,112
+56,956
+796% +$23.2M 0.01% 1022
2022
Q1
$3.92M Sell
7,156
-9,770
-58% -$5.14M ﹤0.01% 3461
2021
Q4
$11.1M Sell
16,926
-3,516
-17% -$2.21M ﹤0.01% 1752
2021
Q3
$12.7M Buy
20,442
+1,316
+7% +$884K ﹤0.01% 1506
2021
Q2
$12.1M Sell
19,126
-5,586
-23% -$3.08M ﹤0.01% 1512
2021
Q1
$12.1M Buy
24,712
+17,623
+249% +$8.83M 0.01% 1378
2020
Q4
$3.54M Buy
7,089
+3,269
+86% +$1.46M ﹤0.01% 2575
2020
Q3
$1.5M Sell
3,820
-3,497
-48% -$1.29M ﹤0.01% 3453
2020
Q2
$2.42M Buy
7,317
+257
+4% +$74.4K ﹤0.01% 2787
2020
Q1
$1.71M Sell
7,060
-2,259
-24% -$590K ﹤0.01% 2171
2019
Q4
$2.43M Buy
9,319
+2,735
+42% +$721K ﹤0.01% 1722
2019
Q3
$1.79M Sell
6,584
-645
-9% -$179K ﹤0.01% 1923
2019
Q2
$1.99M Buy
7,229
+2,991
+71% +$737K ﹤0.01% 1889
2019
Q1
$948K Buy
+4,238
New +$875K ﹤0.01% 2871
2018
Q4
Sell
-6,024
Closed -$1.5M 5281
2018
Q3
$1.5M Buy
6,024
+768
+15% +$186K ﹤0.01% 2237
2018
Q2
$1.15M Buy
5,256
+235
+5% +$48.4K ﹤0.01% 2574
2018
Q1
$961K Sell
5,021
-3,731
-43% -$689K ﹤0.01% 2722
2017
Q4
$1.37M Buy
+8,752
New +$1.38M ﹤0.01% 1975
2017
Q3
Sell
-24,773
Closed -$4M 4724
2017
Q2
$4M Buy
24,773
+17,945
+263% +$2.91M 0.01% 911
2017
Q1
$1.06M Sell
6,828
-11,222
-62% -$1.55M ﹤0.01% 2017
2016
Q4
$2.12M Sell
18,050
-5,143
-22% -$587K 0.01% 1271
2016
Q3
$2.61M Buy
23,193
+16,569
+250% +$1.75M 0.01% 979
2016
Q2
$615K Buy
+6,624
New +$569K ﹤0.01% 2546
2015
Q4
Sell
-21,548
Closed -$1.6M 4195
2015
Q3
$1.6M Buy
21,548
+16,005
+289% +$1.15M 0.01% 1187
2015
Q2
$356K Buy
+5,543
New +$384K ﹤0.01% 2628
2014
Q4
Sell
-4,958
Closed -$292K 2714
2014
Q3
$292K Buy
+4,958
New +$313K ﹤0.01% 1909
2014
Q2
Sell
-14,726
Closed -$894K 2819
2014
Q1
$894K Buy
14,726
+6,444
+78% +$384K 0.01% 1054
2013
Q4
$440K Sell
8,282
-33,502
-80% -$1.76M 0.01% 1331
2013
Q3
$2.08M Buy
41,784
+33,992
+436% +$1.63M 0.02% 557
2013
Q2
$349K Buy
+7,792
New +$340K 0.01% 1751

Other funds holding IDXX

Jane Street's IDXX Position: Q1 2026 in Review

Jane Street increased its Idexx Laboratories (IDXX) stake by 66% in Q1 2026, buying an estimated $3.84M and bringing the position to 14,998 shares worth $8.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2755.

Jane Street first reported a position in IDXX in Q2 2013 and has held it in 45 quarters since. The position peaked at $22.5M in Q2 2022. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Jane Street held 14,998 shares of Idexx Laboratories worth $8.43M as of Q1 2026.
  • Jane Street bought 5,984 Idexx Laboratories shares in Q1 2026, an estimated $3.84M.
  • Idexx Laboratories made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #2755 holding.
  • Jane Street first reported a position in Idexx Laboratories in Q2 2013 and has held it in 45 quarters since.
  • Jane Street's Idexx Laboratories position peaked at $22.5M in Q2 2022.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.